Literature DB >> 29302606

Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: flip side of the story.

Yohannes T Ghebre1.   

Abstract

Entities:  

Keywords:  Antacid therapy; gastroesophageal reflux; idiopathic pulmonary fibrosis; pirfenidone; proton pump inhibitors

Year:  2016        PMID： 29302606      PMCID： PMC5749412          DOI： 10.14800/ics.1397

Source DB:  PubMed          Journal:  Inflamm Cell Signal        ISSN： 2330-7803


× No keyword cloud information.
  9 in total

1.  Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation.

Authors:  Philip A Linden; Richard J Gilbert; Beow Y Yeap; Kathleen Boyle; Aaron Deykin; Michael T Jaklitsch; David J Sugarbaker; Raphael Bueno
Journal:  J Thorac Cardiovasc Surg       Date:  2006-01-18       Impact factor: 5.209

2.  An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.

Authors:  Ganesh Raghu; Bram Rochwerg; Yuan Zhang; Carlos A Cuello Garcia; Arata Azuma; Juergen Behr; Jan L Brozek; Harold R Collard; William Cunningham; Sakae Homma; Takeshi Johkoh; Fernando J Martinez; Jeffrey Myers; Shandra L Protzko; Luca Richeldi; David Rind; Moisés Selman; Arthur Theodore; Athol U Wells; Henk Hoogsteden; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2015-07-15       Impact factor: 21.405

3.  Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis.

Authors:  Michael Kreuter; Wim Wuyts; Elisabetta Renzoni; Dirk Koschel; Toby M Maher; Martin Kolb; Derek Weycker; Paolo Spagnolo; Klaus-Uwe Kirchgaessler; Felix J F Herth; Ulrich Costabel
Journal:  Lancet Respir Med       Date:  2016-03-31       Impact factor: 30.700

4.  Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis.

Authors:  Joyce S Lee; Jay H Ryu; Brett M Elicker; Carmen P Lydell; Kirk D Jones; Paul J Wolters; Talmadge E King; Harold R Collard
Journal:  Am J Respir Crit Care Med       Date:  2011-06-23       Impact factor: 21.405

5.  Antacid therapy and idiopathic pulmonary fibrosis: cause for heartburn?

Authors:  Steven D Nathan
Journal:  Lancet Respir Med       Date:  2016-03-31       Impact factor: 30.700

6.  High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis.

Authors:  G Raghu; T D Freudenberger; S Yang; J R Curtis; C Spada; J Hayes; J K Sillery; C E Pope; C A Pellegrini
Journal:  Eur Respir J       Date:  2006-01       Impact factor: 16.671

7.  Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series.

Authors:  Ganesh Raghu; Steve T-Y Yang; Carolyn Spada; Jennifer Hayes; Carlos A Pellegrini
Journal:  Chest       Date:  2006-03       Impact factor: 9.410

8.  Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.

Authors:  Joyce S Lee; Harold R Collard; Kevin J Anstrom; Fernando J Martinez; Imre Noth; Rhonda S Roberts; Eric Yow; Ganesh Raghu
Journal:  Lancet Respir Med       Date:  2013-06-14       Impact factor: 30.700

9.  Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis.

Authors:  Yohannes T Ghebremariam; John P Cooke; William Gerhart; Carol Griego; Jeremy B Brower; Melanie Doyle-Eisele; Benjamin C Moeller; Qingtao Zhou; Lawrence Ho; Joao de Andrade; Ganesh Raghu; Leif Peterson; Andreana Rivera; Glenn D Rosen
Journal:  J Transl Med       Date:  2015-08-01       Impact factor: 5.531
  9 in total
  1 in total

Review 1.  Proton Pump Inhibitors in IPF: A Call for Clinical Trials.

Authors:  Yohannes T Ghebre
Journal:  Front Pharmacol       Date:  2018-05-17       Impact factor: 5.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.